What news caused Epix to rise 200% today and where did it release first?

The news of ESSA Pharma Inc. (NASDAQ:EPIX) rising by 200% today is likely a result of several factors, including insider trading activity and promising developments in their lead candidate, EPI-7386. 1. **Insider Trading Activity**: Director Franklin Berger's significant purchase of 23,259 shares on November 21, 2023, is a strong vote of confidence in the company's future prospects. Such insider transactions can boost investor confidence and potentially lead to increased investment in the company. 2. **Promising Lead Candidate**: EPI-7386, an androgen receptor-based resistance mechanism, has shown potential in treating castration-resistant prostate cancer and metastatic castration-resistant prostate cancer. The drug's mechanism of action, which targets the N-terminal domain of the androgen receptor, could offer a new approach to overcoming resistance to existing treatments. These factors, among others, could have contributed to the significant increase in EPIX's stock price today. For further details, please see the relevant news sources and the company's corporate presentation on their website.